FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Maarten van Tol

Research Profile

Living Beings

Procedures

Chemicals & Drugs

Anatomy

Disorders

Concepts & Ideas

Co-author Network

Publications

TOP 3
Friso G J Calkoen; Rebecca ten Cate; Monique M van Ostaijen-Ten Dam; Maarten J D van Tol; Carly Vervat; D M C Brinkman; Lynne M Ball
Mesenchymal stromal cells isolated from children with systemic juvenile idiopathic arthritis suppress innate and adaptive immune responses.
CM Jol-van der Zijde; Arjan C Lankester; F J Smiers; R G M Bredius; A M Jansen-Hoogendijk; Maarten J D van Tol
Antibodies to anti-thymocyte globulin in aplastic anemia patients have a negative impact on hematopoietic SCT.
Jens H W Pahl; Kitty M C Kwappenberg; Arjan C Lankester; Maarten J D van Tol; Jort Vellinga; Dirk H J Verhoeven; Marco W Schilham
Adenovirus type 35, but not type 5, stimulates NK cell activation via plasmacytoid dendritic cells and TLR9 signaling.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Maarten van Tol (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Friso G J Calkoen; Rebecca ten Cate; Monique M van Ostaijen-Ten Dam; Maarten J D van Tol; Carly Vervat; D M C Brinkman; Lynne M Ball
Mesenchymal stromal cells isolated from children with systemic juvenile idiopathic arthritis suppress innate and adaptive immune responses.
Cytotherapy 2013;15(3):280-91.
2012: CM Jol-van der Zijde; Arjan C Lankester; F J Smiers; R G M Bredius; A M Jansen-Hoogendijk; Maarten J D van Tol
Antibodies to anti-thymocyte globulin in aplastic anemia patients have a negative impact on hematopoietic SCT.
Bone marrow transplantation 2012;47(9):1256-8.
2012: Jens H W Pahl; Kitty M C Kwappenberg; Arjan C Lankester; Maarten J D van Tol; Jort Vellinga; Dirk H J Verhoeven; Marco W Schilham
Adenovirus type 35, but not type 5, stimulates NK cell activation via plasmacytoid dendritic cells and TLR9 signaling.
Molecular immunology 2012;51(1):91-100.
2012: Yeung-Hyen Kim; Stan Pavel; Jørgen Schøller; Ellen Schrama; Trees A M de Jong; R Maarten Egeler; Claudia M J M Faaij; Els Goulmy; Astrid G S van Halteren; Maarten J D van Tol; Florry A Vyth-Dreese; Eric Spierings
In situ detection of HY-specific T cells in acute graft-versus-host disease-affected male skin after sex-mismatched stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2012;18(3):381-7.
2012: CM Jol-van der Zijde; Arjan C Lankester; S Raaijmakers; R G M Bredius; R Maarten Egeler; A M Jansen-Hoogendijk; Maarten J D van Tol
IgG antibodies to ATG early after pediatric hematopoietic SCT increase the risk of acute GVHD.
Bone marrow transplantation 2012;47(3):360-8.
2011: Louise A Veltrop-Duits; Tamara van Vreeswijk; Bianca Heemskerk; Joyphi C P Thijssen; Ragad El Seady; Els M Jol-van der Zijde; Eric C J Claas; Arjan C Lankester; Maarten J D van Tol; Marco W Schilham
High titers of pre-existing adenovirus serotype-specific neutralizing antibodies in the host predict viral reactivation after allogeneic stem cell transplantation in children.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2011;52(12):1405-13.
2011: Jessica C de Greef; Johan T den Dunnen; Laurence Duprez; Alina Ferster; Rune R Frants; Andrew R Gennery; Giorgio Gimelli; Arjan C Lankester; Ismail Reisli; Catharina Schuetz; Ansgar Schulz; Dominique F C M Smeets; Kirsten R Straasheijm; Yves Sznajer; Peter J van den Elsen; Mirjam van der Burg; Marja C J A van Eggermond; Monique M van Ostaijen-Ten Dam; Maarten J D van Tol; Jun Wang; Corry M Weemaes; Cisca Wijmenga; Caner Aytekin; Judit Balog; Silvère M van der Maarel
Mutations in ZBTB24 are associated with immunodeficiency, centromeric instability, and facial anomalies syndrome type 2.
American journal of human genetics 2011;88(6):796-804.
2011: Kathleen Vrolix; Erik H Niks; Rozen Le Panse; Monique M van Ostaijen-Ten Dam; Anne-Hilde Muris; Cornelia M Jol-van der Zijde; Maarten J D van Tol; Mario Losen; Peter C Molenaar; Everardus J J van Zoelen; Sonia Berrih-Aknin; Marc H De Baets; Jan J Verschuuren; Pilar Martinez-Martinez
Reduced thymic expression of ErbB receptors without auto-antibodies against synaptic ErbB in myasthenia gravis.
Journal of neuroimmunology 2011;232(1-2):158-65.
2011: P Suwannalai; H U Scherer; D van der Woude; Andreea Ioan-Facsinay; CM Jol-van der Zijde; Maarten J D van Tol; Jan Wouter Drijfhout; T W J Huizinga; René E M Toes; Leendert A Trouw
Anti-citrullinated protein antibodies have a low avidity compared with antibodies against recall antigens.
Annals of the rheumatic diseases 2011;70(2):373-9.
2010: Maarten L Zandvliet; J H Frederik Falkenburg; Ellis van Liempt; Louise A Veltrop-Duits; Arjan C Lankester; Jayant S Kalpoe; Michel Kester; Dirk M van der Steen; Maarten J D van Tol; Roel Willemze; Henk-Jan Guchelaar; Marco W Schilham; Pauline Meij
Combined CD8+ and CD4+ adenovirus hexon-specific T cells associated with viral clearance after stem cell transplantation as treatment for adenovirus infection.
Haematologica 2010;95(11):1943-51.
2010: Claudia M J M Faaij; Annemieke J Willemze; Tom Révész; Melania Balzarolo; Cornelis P Tensen; Manja Hoogeboom; Maarten H Vermeer; Elisabeth R van Wering; Christian M Zwaan; Gertjan J L Kaspers; Colin Story; Astrid G S van Halteren; Jaak M Vossen; R Maarten Egeler; Maarten J D van Tol; Nicola E Annels
Chemokine/chemokine receptor interactions in extramedullary leukaemia of the skin in childhood AML: differential roles for CCR2, CCR5, CXCR4 and CXCR7.
Pediatric blood & cancer 2010;55(2):344-8.
2010: S H Chaudhry; S Chaudhry; A M Jansen-Hoogendijk; CM Jol-van der Zijde; Maarten J D van Tol; A Roos; R G M Bredius
Mannose-binding lectin levels and infections in children after allogeneic hematopoietic SCT.
Bone marrow transplantation 2010;45(2):289-93.
2009: Luc B S Gelinck; CM Jol-van der Zijde; Anja M Jansen-Hoogendijk; Daniëlle M C Brinkman; Jaap T van Dissel; Maarten J D van Tol; Frank P Kroon
Restoration of the antibody response upon rabies vaccination in HIV-infected patients treated with HAART.
AIDS (London, England) 2009;23(18):2451-8.
2009: Florence Morfin; Sophie Dupuis-Girod; Emilie Frobert; Stéphanie Mundweiler; David Carrington; Petr Sedlacek; Mare Bierings; Petr Cetkovsky; Aloys C M Kroes; Maarten J D van Tol; Danielle Thouvenot
Differential susceptibility of adenovirus clinical isolates to cidofovir and ribavirin is not related to species alone.
Antiviral therapy 2009;14(1):55-61.
2008: Dirk H J Verhoeven; Alfons S K de Hooge; Esther C K Mooiman; Susy Justo Santos; Monique M ten Dam; Hans Gelderblom; Cornelis J M Melief; Pancras Hogendoorn; R Maarten Egeler; Maarten J D van Tol; Marco W Schilham; Arjan C Lankester
NK cells recognize and lyse Ewing sarcoma cells through NKG2D and DNAM-1 receptor dependent pathways.
Molecular immunology 2008;45(15):3917-25.
2008: Elly van Riet; Kim Retra; Ayola A Adegnika; CM Jol-van der Zijde; H-W Uh; Bertrand Lell; Saadou Issifou; Song Le; Maria Yazdanbakhsh; Maarten J D van Tol; Franca C Hartgers
Cellular and humoral responses to tetanus vaccination in Gabonese children.
Vaccine 2008;26(29-30):3690-5.
2008: Patrizia Comoli; Marco W Schilham; Sabrina Basso; Tamara van Vreeswijk; Maria Ester Bernardo; Rita Maccario; Maarten J D van Tol; Franco Locatelli; Louise A Veltrop-Duits
T-cell lines specific for peptides of adenovirus hexon protein and devoid of alloreactivity against recipient cells can be obtained from HLA-haploidentical donors.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2008;31(6):529-36.
2008: Erik H Niks; A Verrips; B A Semmekrot; M J J Prick; Angela Vincent; Maarten J D van Tol; CM Jol-van der Zijde; Jan J Verschuuren
A transient neonatal myasthenic syndrome with anti-musk antibodies.
Neurology 2008;70(14):1215-6.
2008: Erik H Niks; Y van Leeuwen; M I Leite; F W Dekker; Axel R Wintzen; Paul W Wirtz; Angela Vincent; Maarten J D van Tol; CM Jol-van der Zijde; Jan J Verschuuren
Clinical fluctuations in MuSK myasthenia gravis are related to antigen-specific IgG4 instead of IgG1.
Journal of neuroimmunology 2008;195(1-2):151-6.
2007: D M C Brinkman; CM Jol-van der Zijde; Monique M ten Dam; P A W te Boekhorst; Rebecca ten Cate; Nico M Wulffraat; Rogier Q Hintzen; Jaak M Vossen; Maarten J D van Tol
Resetting the adaptive immune system after autologous stem cell transplantation: lessons from responses to vaccines.
Journal of clinical immunology 2007;27(6):647-58.
2007: Kirsten N Verpoort; E A M Papendrecht-van der Voort; Annette H M Van Der Helm-Van Mil; CM Jol-van der Zijde; Maarten J D van Tol; Jan Wouter Drijfhout; Ferdinand C Breedveld; René R P De Vries; Tom W J Huizinga; René E M Toes
Association of smoking with the constitution of the anti-cyclic citrullinated peptide response in the absence of HLA-DRB1 shared epitope alleles.
Arthritis and rheumatism 2007;56(9):2913-8.
2007: A M Helming; Anneke Brand; Ron Wolterbeek; Maarten J D van Tol; R Maarten Egeler; Lynne M Ball
ABO incompatible stem cell transplantation in children does not influence outcome.
Pediatric blood & cancer 2007;49(3):313-7.
2007: D M C Brinkman; Isme De Kleer; Rebecca ten Cate; Marion A J van Rossum; W Peter Bekkering; Anders Fasth; Maarten J D van Tol; Wietse Kuis; Nico M Wulffraat; Jaak M Vossen
Autologous stem cell transplantation in children with severe progressive systemic or polyarticular juvenile idiopathic arthritis: long-term follow-up of a prospective clinical trial.
Arthritis and rheumatism 2007;56(7):2410-21.
2007: Jayant S Kalpoe; P L J van der Heiden; Renée M Y Barge; Sabine Houtzager; Arjan C Lankester; Maarten J D van Tol; Aloys C M Kroes
Assessment of disseminated adenovirus infections using quantitative plasma PCR in adult allogeneic stem cell transplant recipients receiving reduced intensity or myeloablative conditioning.
European journal of haematology 2007;78(4):314-21.
2007: Aloys C M Kroes; E P A de Klerk; Arjan C Lankester; Corry Malipaard; Caroline S de Brouwer; Eric C J Claas; Els C Jol-van der Zijde; Maarten J D van Tol
Sequential emergence of multiple adenovirus serotypes after pediatric stem cell transplantation.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2007;38(4):341-7.
2007: R G M Bredius; L A E M Laan; Arjan C Lankester; B J H M Poorthuis; Maarten J D van Tol; R M Egeler; W F M Arts
Early marrow transplantation in a pre-symptomatic neonate with late infantile metachromatic leukodystrophy does not halt disease progression.
Bone marrow transplantation 2007;39(5):309-10.
2007: Evelien Zonneveld-Huijssoon; Arash Ronaghy; Marion A J van Rossum; Ger T Rijkers; Fiona R M van der Klis; Elisabeth A M Sanders; Patricia E Vermeer-de Bondt; Arno Hoes; Janjaap van Der Net; Carla Engels; Wietse Kuis; Berent J Prakken; Maarten J D van Tol; Nico M Wulffraat
Safety and efficacy of meningococcal c vaccination in juvenile idiopathic arthritis.
Arthritis and rheumatism 2007;56(2):639-46.
2007: Y K O Teng; Robert J Verburg; Kirsten N Verpoort; Gwendolyn M P Diepenhorst; Ingeborg M Bajema; Maarten J D van Tol; Els C M Jol-van der Zijde; René E M Toes; Tom W J Huizinga; Jacob M van Laar
Differential responsiveness to immunoablative therapy in refractory rheumatoid arthritis is associated with level and avidity of anti-cyclic citrullinated protein autoantibodies: a case study.
Arthritis research & therapy 2007;9(5):R106.
2007: Alfons S K de Hooge; Dagmar Berghuis; Susy Justo Santos; Esther Mooiman; Salvatore Romeo; J Alain Kummer; R Maarten Egeler; Maarten J D van Tol; Cornelis J M Melief; Pancras Hogendoorn; Arjan C Lankester
Expression of cellular FLICE inhibitory protein, caspase-8, and protease inhibitor-9 in Ewing sarcoma and implications for susceptibility to cytotoxic pathways.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(1):206-14.
2006: Bianca Heemskerk; Tamara van Vreeswijk; Louise A Veltrop-Duits; Claudia C Sombroek; Kees L M C Franken; Renate M Verhoosel; Pieter S Hiemstra; Daphne van Leeuwen; Maaike E Ressing; René E M Toes; Maarten J D van Tol; Marco W Schilham
Adenovirus-specific CD4+ T cell clones recognizing endogenous antigen inhibit viral replication in vitro through cognate interaction.
Journal of immunology (Baltimore, Md. : 1950) 2006;177(12):8851-9.
2006: Mirjam van der Burg; Corry M R Weemaes; Frank W M B Preijers; Paul Brons; Barbara H Barendregt; Maarten J D van Tol; Peter Hoogerbrugge; Jacques J M van Dongen
B-cell recovery after stem cell transplantation of Artemis-deficient SCID requires elimination of autologous bone marrow precursor-B-cells.
Haematologica 2006;91(12):1705-9.
2006: Kirsten N Verpoort; CM Jol-van der Zijde; E A M Papendrecht-van der Voort; Andreea Ioan-Facsinay; Jan Wouter Drijfhout; Maarten J D van Tol; Ferdinand C Breedveld; Tom W J Huizinga; René E M Toes
Isotype distribution of anti-cyclic citrullinated peptide antibodies in undifferentiated arthritis and rheumatoid arthritis reflects an ongoing immune response.
Arthritis and rheumatism 2006;54(12):3799-808.
2006: Louise A Veltrop-Duits; Bianca Heemskerk; Claudia C Sombroek; Tamara van Vreeswijk; Sophie Gubbels; René E M Toes; Cornelis J M Melief; Kees L M C Franken; Menzo J E Havenga; Maarten J D van Tol; Marco W Schilham
Human CD4+ T cells stimulated by conserved adenovirus 5 hexon peptides recognize cells infected with different species of human adenovirus.
European journal of immunology 2006;36(9):2410-23.
2006: Ellen A J Thomassen; E H A Dekking; A Thompson; Kees L M C Franken; O Sanal; Jan Pieter Abrahams; Maarten J D van Tol; Frits Koning
The impact of single amino acid substitutions in CD3gamma on the CD3epsilongamma interaction and T-cell receptor-CD3 complex formation.
Human immunology 2006;67(8):579-88.
2006: José A M Borghans; R G M Bredius; Mette D Hazenberg; Helene Roelofs; Els C Jol-van der Zijde; Jeroen Heidt; Sigrid A Otto; Taco W Kuijpers; Willem E Fibbe; Jaak M Vossen; Frank Miedema; Maarten J D van Tol
Early determinants of long-term T-cell reconstitution after hematopoietic stem cell transplantation for severe combined immunodeficiency.
Blood 2006;108(2):763-9.
2006: Nicola E Annels; Jayant S Kalpoe; R G M Bredius; Eric C J Claas; Aloys C M Kroes; Andrew D Hislop; Debbie Van Baarle; R Maarten Egeler; Maarten J D van Tol; Arjan C Lankester
Management of Epstein-Barr virus (EBV) reactivation after allogeneic stem cell transplantation by simultaneous analysis of EBV DNA load and EBV-specific T cell reconstitution.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;42(12):1743-8.
2006: Claudia M J M Faaij; Arjan C Lankester; Eric Spierings; Manja Hoogeboom; Edward P Bowman; Marc Bierings; Tom Révész; R Maarten Egeler; Maarten J D van Tol; Nicola E Annels
A possible role for CCL27/CTACK-CCR10 interaction in recruiting CD4 T cells to skin in human graft-versus-host disease.
British journal of haematology 2006;133(5):538-49.
2006: Menno van Zelm; Ismail Reisli; Mirjam van der Burg; Diana Castaño; Carel J M van Noesel; Maarten J D van Tol; Cristina Woellner; Bodo Grimbacher; Pablo Patino; Jacques J M van Dongen; José L Franco
An antibody-deficiency syndrome due to mutations in the CD19 gene.
The New England journal of medicine 2006;354(18):1901-12.
2005: Maarten J D van Tol; Aloys C M Kroes; Janke Schinkel; W Dinkelaar; Eric C J Claas; CM Jol-van der Zijde; Jaak M Vossen
Adenovirus infection in paediatric stem cell transplant recipients: increased risk in young children with a delayed immune recovery.
Bone marrow transplantation 2005;36(1):39-50.
2005: Arjan C Lankester; L F A Visser; Nico G Hartwig; R G M Bredius; H B Gaspar; Mirjam van der Burg; Maarten J D van Tol; T G Gross; R Maarten Egeler
Allogeneic stem cell transplantation in X-linked lymphoproliferative disease: two cases in one family and review of the literature.
Bone marrow transplantation 2005;36(2):99-105.
2005: Eric C J Claas; Marco W Schilham; Caroline S de Brouwer; Petr Hubacek; Marcela Echavarria; Arjan C Lankester; Maarten J D van Tol; Aloys C M Kroes
Internally controlled real-time PCR monitoring of adenovirus DNA load in serum or plasma of transplant recipients.
Journal of clinical microbiology 2005;43(4):1738-44.
2005: Maarten J D van Tol; Eric C J Claas; Bianca Heemskerk; Louise A Veltrop-Duits; Caroline S de Brouwer; Tamara van Vreeswijk; Claudia C Sombroek; Aloys C M Kroes; Matthias F C Beersma; E P A de Klerk; R Maarten Egeler; Arjan C Lankester; Marco W Schilham
Adenovirus infection in children after allogeneic stem cell transplantation: diagnosis, treatment and immunity.
Bone marrow transplantation 2005;35 Suppl 1():S73-6.
2005: Lynne M Ball; Arjan C Lankester; R G M Bredius; Willem E Fibbe; Maarten J D van Tol; R Maarten Egeler
Graft dysfunction and delayed immune reconstitution following haploidentical peripheral blood hematopoietic stem cell transplantation.
Bone marrow transplantation 2005;35 Suppl 1():S35-8.
2005: Bianca Heemskerk; Arjan C Lankester; Tamara van Vreeswijk; Matthias F C Beersma; Eric C J Claas; Louise A Veltrop-Duits; Aloys C M Kroes; Jaak M Vossen; Marco W Schilham; Maarten J D van Tol
Immune reconstitution and clearance of human adenovirus viremia in pediatric stem-cell recipients.
The Journal of infectious diseases 2005;191(4):520-30.
2005: Florence Morfin; Sophie Dupuis-Girod; Stéphanie Mundweiler; Delphine Falcon; David Carrington; Petr Sedlacek; Marc Bierings; Petr Cetkovsky; Aloys C M Kroes; Maarten J D van Tol; Danielle Thouvenot
In vitro susceptibility of adenovirus to antiviral drugs is species-dependent.
Antiviral therapy 2005;10(2):225-9.
2004: Riny Janssen; Annelies van Wengen; Marieke A Hoeve; Monique M ten Dam; Mirjam van der Burg; Jacques Van Dongen; Esther van de Vosse; Maarten J D van Tol; R G M Bredius; Tom H M Ottenhoff; Corry M R Weemaes; Jaap T van Dissel; Arjan C Lankester
The same IkappaBalpha mutation in two related individuals leads to completely different clinical syndromes.
The Journal of experimental medicine 2004;200(5):559-68.
2004: Arjan C Lankester; Bianca Heemskerk; Eric C J Claas; Marco W Schilham; Matthias F C Beersma; R G M Bredius; Maarten J D van Tol; Aloys C M Kroes
Effect of ribavirin on the plasma viral DNA load in patients with disseminating adenovirus infection.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;38(11):1521-5.
2004: A G S C Jansen; Jeroen G Noordzij; Annette H J T Bröcker-Vriends; Jacques J M van Dongen; Maarten J D van Tol; R G M Bredius
[Widely divergent clinical phenotype of x-linked agammaglobulinemia in two cousins].
Nederlands tijdschrift voor geneeskunde 2004;148(21):1053-6.
2004: Nicola E Annels; Annemieke J Willemze; V H J van der Velden; Claudia M J M Faaij; Elisabeth R van Wering; Daisy M D S Sie-Go; R Maarten Egeler; Maarten J D van Tol; Tom Révész
Possible link between unique chemokine and homing receptor expression at diagnosis and relapse location in a patient with childhood T-ALL.
Blood 2004;103(7):2806-8.
2003: D M C Brinkman; CM Jol-van der Zijde; Monique M ten Dam; Jaak M Vossen; A D M E Osterhaus; Frank P Kroon; Maarten J D van Tol
Vaccination with rabies to study the humoral and cellular immune response to a T-cell dependent neoantigen in man.
Journal of clinical immunology 2003;23(6):528-38.
2003: Arnout Jan de Beaufort; Astrid C Bakker; Maarten J D van Tol; B J H M Poorthuis; Alexandra J Schrama; Howard M Berger
Meconium is a source of pro-inflammatory substances and can induce cytokine production in cultured A549 epithelial cells.
Pediatric research 2003;54(4):491-5.
2003: Bianca Heemskerk; Louise A Veltrop-Duits; Tamara van Vreeswijk; Monique M ten Dam; Sebastiaan Heidt; René E M Toes; Maarten J D van Tol; Marco W Schilham
Extensive cross-reactivity of CD4+ adenovirus-specific T cells: implications for immunotherapy and gene therapy.
Journal of virology 2003;77(11):6562-6.
2003: Petra M.C. Callenbach; CM Jol-van der Zijde; Ada T Geerts; W F M Arts; Cees A Van Donselaar; A C B Peters; Hans Stroink; Oebele F Brouwer; Maarten J D van Tol
Immunoglobulins in children with epilepsy: the Dutch Study of Epilepsy in Childhood.
Clinical and experimental immunology 2003;132(1):144-51.
2002: Rebecca ten Cate; D M C Brinkman; Marion A J van Rossum; Arjan C Lankester; R G M Bredius; Maarten R M Egeler; Maarten J D van Tol; Jaak M Vossen
Macrophage activation syndrome after autologous stem cell transplantation for systemic juvenile idiopathic arthritis.
European journal of pediatrics 2002;161(12):686-6.
2002: Marco W Schilham; Eric C J Claas; Wouter van Zaane; Bianca Heemskerk; Jaak M Vossen; Arjan C Lankester; Rene E Toes; Marcela Echavarria; Aloys C M Kroes; Maarten J D van Tol
High levels of adenovirus DNA in serum correlate with fatal outcome of adenovirus infection in children after allogeneic stem-cell transplantation.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;35(5):526-32.
2002: Arjan C Lankester; Maarten J D van Tol; Jaak M Vossen; Aloys C M Kroes; Eric C J Claas
Epstein-Barr virus (EBV)-DNA quantification in pediatric allogenic stem cell recipients: prediction of EBV-associated lymphoproliferative disease.
Blood 2002;99(7):2630-1.
2002: Arjan C Lankester; Maarten J D van Tol; Eric C J Claas; Jaak M Vossen; Aloys C M Kroes
Quantification of adenovirus DNA in plasma for management of infection in stem cell graft recipients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;34(6):864-7.
2002: Mijke A Breukels; Els Jol-van der Zijde; Maarten J D van Tol; Ger T Rijkers
Concentration and avidity of anti-Haemophilus influenzae type b (Hib) antibodies in serum samples obtained from patients for whom Hib vaccination failed.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;34(2):191-7.
2001: Marcela Echavarria; M Forman; Maarten J D van Tol; Jaak M Vossen; PATRICIA CHARACHE; Aloys C M Kroes
Prediction of severe disseminated adenovirus infection by serum PCR.
Lancet 2001;358(9279):384-5.
2001: Barbara C Godthelp; Maarten J D van Tol; Jaak M Vossen; Peter J van den Elsen
Longitudinal analysis of T cells responding to tetanus toxoid in healthy subjects as well as in pediatric patients after bone marrow transplantation: the identification of identical TCR-CDR3 regions in time suggests long-term stability of at least part of the antigen-specific TCR repertoire.
International immunology 2001;13(4):507-18.
2000: E de Vries; T W Kuijpers; Maarten J D van Tol; J W van der Meer; C M Weemaes; J J van Dongen
[Immunology in medical practice. XXXV. Screening of suspected immunodeficiency: diagnostic protocols for patients with opportunistic or recurrent severe infections, wasting and failure to thrive].
Nederlands tijdschrift voor geneeskunde 2000;144(46):2197-203.
2000: E de Vries; T W Kuijpers; Maarten J D van Tol; J W van der Meer; C M Weemaes; J J van Dongen
[Immunology in medical practice. XXXIV. Screening for suspected immunodeficiency: Introduction].
Nederlands tijdschrift voor geneeskunde 2000;144(46):2192-6.
2000: Barbara C Godthelp; Marja C J A van Eggermond; Maarten J D van Tol; Jaak M Vossen; Peter J van den Elsen
T cell immune reconstitution after allogeneic bone marrow transplantation in bare lymphocyte syndrome.
Human immunology 2000;61(9):898-907.
2000: E de Vries; Maarten J D van Tol; R L van den Bergh; J L Waaijer; Monique M ten Dam; J Hermans; Jaak M Vossen
Reconstitution of lymphocyte subpopulations after paediatric bone marrow transplantation.
Bone marrow transplantation 2000;25(3):267-75.
1999: Barbara C Godthelp; Maarten J D van Tol; Jaak M Vossen; Peter J van den Elsen
T-Cell immune reconstitution in pediatric leukemia patients after allogeneic bone marrow transplantation with T-cell-depleted or unmanipulated grafts: evaluation of overall and antigen-specific T-cell repertoires.
Blood 1999;94(12):4358-69.
1999: Manou R Batstra; A van Driel; JS Petersen; Cees A Van Donselaar; Maarten J D van Tol; G Jan Bruining; Diederick Grobbee; Thomas Dyrberg; Henk-Jan Aanstoot
Glutamic acid decarboxylase antibodies in screening for autoimmune diabetes: influence of comorbidity, age, and sex on specificity and threshold values.
Clinical chemistry 1999;45(12):2269-72.
1999: E de Vries; Jeroen G Noordzij; E G Davies; Nico G Hartwig; M H Breuning; Jacques J M van Dongen; Maarten J D van Tol
The 78C --> T (T254M) XHIM mutation: lack of a tight phenotype-genotype relationship.
Blood 1999;94(4):1488-90.
1999: Barbara C Godthelp; Marja C J A van Eggermond; Ad Peijnenburg; Ilhan Tezcan; S van Lierde; Maarten J D van Tol; Jaak M Vossen; Peter J van den Elsen
Incomplete T-cell immune reconstitution in two major histocompatibility complex class II-deficiency/bare lymphocyte syndrome patients after HLA-identical sibling bone marrow transplantation.
Blood 1999;94(1):348-58.
1999: Frank P Kroon; Maarten J D van Tol; CM Jol-van der Zijde; Ralph van Furth; Jaap T van Dissel
Immunoglobulin G (IgG) subclass distribution and IgG1 avidity of antibodies in human immunodeficiency virus-infected individuals after revaccination with tetanus toxoid.
Clinical and diagnostic laboratory immunology 1999;6(3):352-5.
1999: Iris de Bruijn; Edmond J Remarque; CM Jol-van der Zijde; Maarten J D van Tol; Rudi G J Westendorp; Dick L Knook
Quality and quantity of the humoral immune response in healthy elderly and young subjects after annually repeated influenza vaccination.
The Journal of infectious diseases 1999;179(1):31-6.
1998: Monique M ten Dam; Y van de Wal; M Luisa Mearin; Yvonne M C Kooy; Amado Salvador Peña; Jan Wouter Drijfhout; Frits Koning; Maarten J D van Tol
Anti-alpha-gliadin antibodies (AGA) in the serum of coeliac children and controls recognize an identical collection of linear epitopes of alpha-gliadin.
Clinical and experimental immunology 1998;114(2):189-95.
1998: Barbara C Godthelp; Maarten J D van Tol; Jaak M Vossen; Peter J van den Elsen
Long-term T cell immune reconstitution in 2 SCID patients after BMT.
Human immunology 1998;59(4):225-38.
1998: Maarten J D van Tol; R Langlois van den Bergh; Wilma E Mesker; MC Ouwerkerk-van Velzen; Jaak M Vossen; Hans J Tanke
Simultaneous detection of X and Y chromosomes by two-colour fluorescence in situ hybridization in combination with immunophenotyping of single cells to document chimaerism after sex-mismatched bone marrow transplantation.
Bone marrow transplantation 1998;21(5):497-503.
1997: Frank M Raaphorst; R Langlois van den Bergh; J L Waaijer; Jaak M Vossen; Maarten J D van Tol
Expression of the human immunoglobulin heavy chain VH6 gene element by fetal B lymphocytes.
Scandinavian journal of immunology 1997;46(3):292-7.
1996: E de Vries; HR Koene; Jaak M Vossen; J W Gratama; Albert E G Kr von dem Borne; J L Waaijer; A Haraldsson; Masja de Haas; Maarten J D van Tol
Identification of an unusual Fc gamma receptor IIIa (CD16) on natural killer cells in a patient with recurrent infections.
Blood 1996;88(8):3022-7.
1996: E J Gerritsen; E D Stam; J Hermans; H van den Berg; A Haraldsson; Maarten J D van Tol; R L van den Bergh; J L Waaijer; A C Kroes; P M Kluin; Jaak M Vossen
Risk factors for developing EBV-related B cell lymphoproliferative disorders (BLPD) after non-HLA-identical BMT in children.
Bone marrow transplantation 1996;18(2):377-82.
1996: E J Gerritsen; Maarten J D van Tol; P Ballieux; A Voesten; H T Weiland; W J van Venrooij; M R Daha; H G Geertzen; G T Rijkers; F H Gmelig-Meyling; F J Claas; J Radl; Jaak M Vossen
Search for the antigen-specificity of homogeneous IgG components (H-IgG) after allogeneic bone marrow transplantation.
Bone marrow transplantation 1996;17(5):825-33.
1996: E J Gerritsen; E D Stam; H Van den Berg; A Haraldsson; Maarten J D van Tol; Jaak M Vossen
Follow-up of leucocyte and reticulocyte counts for the prediction of early graft failure after non-HLA-identical BMT in children.
Bone marrow transplantation 1996;17(5):781-7.
1996: Masja de Haas; HR Koene; Marion Kleijer; E de Vries; S Simsek; Maarten J D van Tol; Dirk Roos; Albert E G Kr von dem Borne
A triallelic Fc gamma receptor type IIIA polymorphism influences the binding of human IgG by NK cell Fc gamma RIIIa.
Journal of immunology (Baltimore, Md. : 1950) 1996;156(8):2948-55.
1996: J Henwood; Marja C J A van Eggermond; A H van Boxel-Dezaire; R Schipper; M den Hoedt; Ad Peijnenburg; O Sanal; F Ersoy; G T Rijkers; B J Zegers; Jaak M Vossen; Maarten J D van Tol; Peter J van den Elsen
Human T cell repertoire generation in the absence of MHC class II expression results in a circulating CD4+CD8- population with altered physicochemical properties of complementarity-determining region 3.
Journal of immunology (Baltimore, Md. : 1950) 1996;156(3):895-906.
1996: Maarten J D van Tol; E J Gerritsen; G G de Lange; A M van Leeuwen; CM Jol-van der Zijde; N J Oudeman-Gruber; E de Vries; J Radl; Jaak M Vossen
The origin of IgG production and homogeneous IgG components after allogeneic bone marrow transplantation.
Blood 1996;87(2):818-26.
1994: E J Gerritsen; Maarten J D van Tol; M B Van 't Veer; J M Wels; I M Khouw; C R Touw; CM Jol-van der Zijde; J Hermans; H C Rümke; J Radl
Clonal dysregulation of the antibody response to tetanus-toxoid after bone marrow transplantation.
Blood 1994;84(12):4374-82.
1994: J E van Leeuwen; Maarten J D van Tol; A M Joosten; P T Schellekens; R L van den Bergh; J L Waaijer; N J Oudeman-Gruber; C P van der Weijden-Ragas; M T Roos; E J Gerritsen
Relationship between patterns of engraftment in peripheral blood and immune reconstitution after allogeneic bone marrow transplantation for (severe) combined immunodeficiency.
Blood 1994;84(11):3936-47.
1994: J E van Leeuwen; Maarten J D van Tol; A M Joosten; Juul Wijnen; P J Verweij; PM Khan; Jaak M Vossen
Persistence of host-type hematopoiesis after allogeneic bone marrow transplantation for leukemia is significantly related to the recipient's age and/or the conditioning regimen, but it is not associated with an increased risk of relapse.
Blood 1994;83(10):3059-67.
1994: H van den Berg; E J Gerritsen; Maarten J D van Tol; L J Dooren; Jaak M Vossen
Ten years after acquiring an HIV-1 infection: a study in a cohort of eleven neonates infected by aliquots from a single plasma donation.
Acta paediatrica (Oslo, Norway : 1992) 1994;83(2):173-8.
1993: E J Gerritsen; Maarten J D van Tol; A C Lankester; C P van der Weijden-Ragas; CM Jol-van der Zijde; N J Oudeman-Gruber; J Radl; Jaak M Vossen
Immunoglobulin levels and monoclonal gammopathies in children after bone marrow transplantation.
Blood 1993;82(11):3493-502.
1993: J E van Leeuwen; Maarten J D van Tol; A M Joosten; Juul Wijnen; PM Khan; Jaak M Vossen
Mixed T-lymphoid chimerism after allogeneic bone marrow transplantation for hematologic malignancies of children is not correlated with relapse.
Blood 1993;82(6):1921-8.
1993: B W van der Meer; M L Mearin; A S Peña; Maarten J D van Tol; C B Lamers; L J Dooren
[The clinical significance of anti-gliadin antibodies determination in blood of children with suspected celiac diseases].
Tijdschrift voor kindergeneeskunde 1993;61(1):7-12.
1993: J H Van Es; F M Raaphorst; Maarten J D van Tol; F H Meyling; Ton Logtenberg
Expression pattern of the most JH-proximal human VH gene segment (VH6) in the B cell and antibody repertoire suggests a role of VH6-encoded IgM antibodies in early ontogeny.
Journal of immunology (Baltimore, Md. : 1950) 1993;150(1):161-8.
1993: Jaak M Vossen; J E van Leeuwen; Maarten J D van Tol; A M Joosten; H van den Berg; E J Gerritsen; A Haraldsson; PM Khan
Chimerism and immune reconstitution following allogeneic bone marrow transplantation for severe combined immunodeficiency disease.
Immunodeficiency 1993;4(1-4):311-3.
1992: H van den Berg; Maarten J D van Tol; N J Oudeman-Gruber; J L Waaijer; G Wagemaker; Jaak M Vossen
Validation of a serum-free growth factor-replenished in vitro culture system for hematopoietic progenitor cells in healthy donors and recipients of an allogeneic bone marrow graft.
European journal of haematology 1992;49(5):269-74.
1992: J Labadie; Maarten J D van Tol; N H Dijkstra; M van der Kaaden; CM Jol-van der Zijde; G G de Lange; F E Zwaan; Jaak M Vossen
Transfer of specific immunity from donor to recipient of an allogeneic bone marrow graft: evidence for donor origin of the antibody producing cells.
British journal of haematology 1992;82(2):437-44.
1992: J Labadie; Maarten J D van Tol; N H Dijkstra; F E Zwaan; Jaak M Vossen
Transfer of specific immunity from donor to recipient of an allogeneic bone marrow graft: effect of conditioning on the specific immune response of the graft recipient.
British journal of haematology 1992;80(3):381-90.
1992: H van den Berg; Maarten J D van Tol; J L Waaijer; N J Oudeman-Gruber; Jaak M Vossen
Study of possible correlations between in vitro growth of bone marrow stromal and hematopoietic precursor cells early after allogeneic bone marrow transplantation.
Experimental hematology 1992;20(2):184-91.
1992: F M Raaphorst; E Timmers; M J Kenter; Maarten J D van Tol; Jaak M Vossen; R K Schuurman
Restricted utilization of germ-line VH3 genes and short diverse third complementarity-determining regions (CDR3) in human fetal B lymphocyte immunoglobulin heavy chain rearrangements.
European journal of immunology 1992;22(1):247-51.
1992: G E De Greef; Maarten J D van Tol; J W Van Den Berg; G J Van Staalduinen; C J Janssen; J Radl; W Hijmans
Serum immunoglobulin class and IgG subclass levels and the occurrence of homogeneous immunoglobulins during the course of ageing in humans.
Mechanisms of ageing and development 1992;66(1):29-44.
1992: G E De Greef; Maarten J D van Tol; C G Kallenberg; G J Van Staalduinen; Edmond J Remarque; Y I Tjandra; W Hijmans
Influence of ageing on antibody formation in vivo after immunisation with the primary T-cell dependent antigen Helix pomatia haemocyanin.
Mechanisms of ageing and development 1992;66(1):15-28.
1992: G E De Greef; G J Van Staalduinen; H Van Doorninck; Maarten J D van Tol; W Hijmans
Age-related changes of the antigen-specific antibody formation in vitro and PHA-induced T-cell proliferation in individuals who met the health criteria of the Senieur protocol.
Mechanisms of ageing and development 1992;66(1):1-14.
1991: J E van Leeuwen; Maarten J D van Tol; B G Bodzinga; Juul Wijnen; M van der Keur; A M Joosten; Hans J Tanke; Jaak M Vossen; PM Khan
Detection of mixed chimaerism in flow-sorted cell subpopulations by PCR-amplified VNTR markers after allogeneic bone marrow transplantation.
British journal of haematology 1991;79(2):218-25.
1991: H van den Berg; Jaak M Vossen; R Langlois van den Bergh; Jan Bayer; Maarten J D van Tol
Detection of Y chromosome by in situ hybridization in combination with membrane antigens by two-color immunofluorescence.
Laboratory investigation; a journal of technical methods and pathology 1991;64(5):623-8.
1990: F J Nooij; A J Van der Sluijs-Gelling; CM Jol-van der Zijde; Maarten J D van Tol; H Haas; J Radl
Immunoblotting techniques for the detection of low level homogeneous immunoglobulin components in serum.
Journal of immunological methods 1990;134(2):273-81.
1989: E Gerritsen; Jaak M Vossen; Maarten J D van Tol; CM Jol-van der Zijde; R Van der Weijden-Ragas; J Radl
Monoclonal gammopathies in children.
Journal of clinical immunology 1989;9(4):296-305.
1989: Rudolf W Hendriks; Maarten J D van Tol; G G de Lange; R K Schuurman
Inheritance of a large deletion within the human immunoglobulin heavy chain constant region gene complex and immunological implications.
Scandinavian journal of immunology 1989;29(5):535-41.
1988: E J Gerritsen; H van den Berg; R L Langlois van den Bergh; P T Schellekens; Maarten J D van Tol; L J Dooren; Jaak M Vossen
[Combined immunologic deficiency].
Tijdschrift voor kindergeneeskunde 1988;56(5):196-205.
1988: CM Jol-van der Zijde; J Labadie; A Vlug; J Radl; Jaak M Vossen; Maarten J D van Tol
Dot-immunobinding assay as an accurate and versatile technique for the quantification of human IgG subclasses.
Journal of immunological methods 1988;108(1-2):195-203.
1988: J Radl; CM Jol-van der Zijde; Maarten J D van Tol; Jaak M Vossen
IgG subclass representation within homogeneous immunoglobulins in immunodeficiency diseases.
Monographs in allergy 1988;23():78-82.